Companies
Getein Biotech
Nanjing-based rapid POCT immunoassay maker (cardiac and inflammatory markers) scaling affordable point-of-care panels.
- Country
- China
point-of-care
cn
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | March 2002 | getein.com |
| Headquarters | No.9 Bofu Road, Luhe District, Nanjing, China | getein.com |
| Revenue | CNY 1.05 billion (for the fiscal year ended December 31, 2025) | stockanalysis.com · uk.marketscreener.com · getein.com |
| Headcount | Over 1,700 staff | getein.com |
| Certification | ISO9001:2015, ISO13485:2016, MDSAP, and BGMP/IVDR | getein.com |
| Regulatory approval | CE IVDR, US FDA, Brazil ANVISA, UK MHRA, Australia TGA, Indonesia AKL, Canada HC, Japan MHLW; 4,420 total product registration certificates as of end of 2025 | getein.com |
| Production site | No.9 Bofu Road, Luhe District, Nanjing; also reported at No. 4306 Zhujiang Road, Xuanwu District, Nanjing | getein001.en.made-in-china.com · getein.com |
| Capacity | Above 10 production lines medium confidence | getein001.en.made-in-china.com |
Independent sources: getein001.en.made-in-china.com · stockanalysis.com · uk.marketscreener.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Diagnostics & biosensors | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.